These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23389975)

  • 41. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
    van der Steen M; Leenstra T; Kluytmans JA; van der Bij AK;
    PLoS One; 2015; 10(9):e0138088. PubMed ID: 26381746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
    Martinez P; Garzón D; Mattar S
    Braz J Infect Dis; 2012; 16(5):420-5. PubMed ID: 22964287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
    Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
    J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The detection of ESBL-producing Escherichia coli in patients with symptomatic urinary tract infections using different diffusion methods in a rural setting.
    Harwalkar A; Sataraddi J; Gupta S; Yoganand R; Rao A; Srinivasa H
    J Infect Public Health; 2013 Apr; 6(2):108-14. PubMed ID: 23537823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antimicrobial activity of sulbactam/cefoperazone. Comparison with other new cephems].
    Deguchi K; Yokota N; Koguchi M; Fukayama S; Nishimura Y; Nakane Y; Oda S; Tanaka S; Kato M; Sato K
    Jpn J Antibiot; 1987 Oct; 40(10):1752-61. PubMed ID: 3444015
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antimicrobial resistance of Escherichia coli isolates from broiler chickens and humans.
    Miles TD; McLaughlin W; Brown PD
    BMC Vet Res; 2006 Feb; 2():7. PubMed ID: 16460561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
    Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
    Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A2 enzymes.
    Perumal Samy R; Gopalakrishnakone P; Thwin MM; Chow TK; Bow H; Yap EH; Thong TW
    J Appl Microbiol; 2007 Mar; 102(3):650-9. PubMed ID: 17309613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the administration of a third-generation cephalosporin (3GC) to one-day-old chicks on the persistence of 3GC-resistant Escherichia coli in intestinal flora: An in vivo experiment.
    Baron S; Jouy E; Touzain F; Bougeard S; Larvor E; de Boisseson C; Amelot M; Keita A; Kempf I
    Vet Microbiol; 2016 Mar; 185():29-33. PubMed ID: 26931388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial resistance among urinary tract Escherichia coli isolates from inpatients and outpatients in a tertiary care center in São Paulo, Brazil.
    Santo E; Salvador MM; Marin JM
    Int J Infect Dis; 2007 Nov; 11(6):558-9. PubMed ID: 17512771
    [No Abstract]   [Full Text] [Related]  

  • 57. Cephalosporin Resistance in
    Wang M; Zu X; Zhao Z; Fu F; Bai X; Gong X; Zhao P; Gao W; Xue Y
    Microb Drug Resist; 2020 Oct; 26(10):1250-1259. PubMed ID: 32013730
    [No Abstract]   [Full Text] [Related]  

  • 58. Snake Cathelicidin NA-CATH and Smaller Helical Antimicrobial Peptides Are Effective against Burkholderia thailandensis.
    Blower RJ; Barksdale SM; van Hoek ML
    PLoS Negl Trop Dis; 2015; 9(7):e0003862. PubMed ID: 26196513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of ceragenins as a potential treatment for urinary tract infections.
    Wnorowska U; Piktel E; Durnaś B; Fiedoruk K; Savage PB; Bucki R
    BMC Infect Dis; 2019 May; 19(1):369. PubMed ID: 31046689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental colonization of the canine urinary tract with the asymptomatic bacteriuria Escherichia coli strain 83972.
    Thompson MF; Totsika M; Schembri MA; Mills PC; Seton EJ; Trott DJ
    Vet Microbiol; 2011 Jan; 147(1-2):205-8. PubMed ID: 20638202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.